IP Library Granted Patent US 7,588,937
Granted Patent B2
US 7,588,937 · App. 10/928,805 · Granted Sep 15, 2009

Method of in vitro differentiation of neural stem cells, motor neurons and dopamine neurons from primate embryonic stem cells

Assignee: Wisconsin Alumni Research Foundation
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,588,937
App. No.
10/928,805
Granted
Sep 15, 2009
Kind
B2
Abstract

A method of differentiating embryonic stem cells into neural and motor cells is disclosed. In one embodiment, the invention comprises culturing a population of cells comprising a majority of cells that are characterized by an early rosette morphology and are Sox1 − /Pax6 + in the presence of FGF2, FGF4, FGF8, FGF 9, or RA wherein the cells are characterized by an neural tube-like rosette morphology and are Pax6 + /Sox1 + .

Claims (6)

1. A method of obtaining a population of midbrain dopamine neurons, comprising:

(a) obtaining a synchronous population of cells that are cultured from embryonic stem cells, and which are characterized by an early rosette morphology and are Sox1 − , Pax6 + ;

(b) culturing the cells obtained in (a) in a neural basal medium with fibroblast growth factor-8 (FGF8), wherein resulting cells are Pax6 + , Sox1 + and engrailed 1 positive (EN-1+) neuroepithelial cells;

(c) expanding the cells from step (b) in a neural basal medium with sonic hedgehog (SHH) and FGF8, wherein resulting cells are dopaminergic neural precursors; and

(d) culturing the cells from step (c) in a neural basal differentiation medium without SHH and FGF8 until resulting cells express tyrosine hydroxylase (TH), aromatic acid decarboxylase (AADC), EN-1, vesicular monoamine transporter 2 (VMAT2) and dopamine transporter (DAT) but do not express dopamine beta hydroxylase (DbH) and phenylethanolamine N-methyltransferase (PNMT), and produce dopamine.

2. The method of claim 1 , wherein the exposure to SHH is between 6-7 days.

Assignments (2)
CONFIRMATORY LICENSE Recorded Jul 25, 2011
From: WISCONSIN ALUMNI RESEARCH FOUNDATION
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 026639/0495 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 15, 2004
From: ZHANG, SU-CHUN; THOMSON, JAMES A.; DUNCAN, IAN D.; LI, XUE-JUN
To: WISCONSIN ALUMNI RESEARCH FOUNDATION
Reel/Frame 015455/0689 →
Continuity (4)
Continuation In Part 0997038200 · Oct 3, 2001
Provisional Application 6049883100 · Aug 29, 2003
Provisional Application 6049957000 · Sep 2, 2003
Related Publication 20050095706A1 · May 5, 2005